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Abstract
The methylation of cytosines in CpG dinucleotides is essential for cellular differentiation and the progression of many
cancers, and it plays an important role in gametic imprinting. To assess variation and inheritance of genome-wide patterns
of DNA methylation simultaneously in humans, we applied reduced representation bisulfite sequencing (RRBS) to somatic
DNA from six members of a three-generation family. We observed that 8.1% of heterozygous SNPs are associated with
differential methylation in cis, which provides a robust signature for Mendelian transmission and relatedness. The vast
majority of differential methylation between homologous chromosomes (.92%) occurs on a particular haplotype as
opposed to being associated with the gender of the parent of origin, indicating that genotype affects DNA methylation of
far more loci than does gametic imprinting. We found that 75% of genotype-dependent differential methylation events in
the family are also seen in unrelated individuals and that overall genotype can explain 80% of the variation in DNA
methylation. These events are under-represented in CpG islands, enriched in intergenic regions, and located in regions of
low evolutionary conservation. Even though they are generally not in functionally constrained regions, 22% (twice as many
as expected by chance) of genes harboring genotype-dependent DNA methylation exhibited allele-specific gene expression
as measured by RNA-seq of a lymphoblastoid cell line, indicating that some of these events are associated with gene
expression differences. Overall, our results demonstrate that the influence of genotype on patterns of DNA methylation is
widespread in the genome and greatly exceeds the influence of imprinting on genome-wide methylation patterns.
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Introduction
Methylation of the 5 carbon of a large number of cytosines in
the genome is necessary in mammalian development [1]. Aberrant
patterns of DNA methylation have been reported in a wide variety
of human diseases, including cancer [2,3], psychiatric disorders
[4], autoimmune diseases [5] and diabetes [6]. Some of these
patterns are indicative of underlying functional changes that have
occurred during disease progression and shed light on genes
involved in pathogenesis. One of the most fascinating discoveries
surrounding DNA methylation is the observation that two
homologous chromosomes can be differentially methylated.
Differential methylation of homologous chromosomes can be
the result of epigenetic phenomena such as gametic imprinting
[7,8] or X chromosome inactivation [9,10]. DNA sequence, or
genotype, may also play a role in establishing differential
methylation, as a few well-established cases have been identified
in which a locus’ DNA methylation state clearly depends on an
individual’s DNA sequence [11,12]. Recent advances in DNA
sequencing technology have opened the door to exploring
differential methylation on homologous chromosomes with high
accuracy and detail. It is now possible to examine the prevalence
of genetic versus epigenetic causes of differential methylation with
unprecedented precision and thoroughness.
To distinguish the impact of gametic imprinting vs. genotype on
DNA methylation, the inheritance patterns of alleles along with
corresponding methylation levels should be observed. Recent
studies have suggested that the majority of differential DNA
methylation on homologous chromosomes is sequence-dependent
and not the result of gametic imprinting, as the same allele has the
same influence on DNA methylation in unrelated individuals [13–
15]. However, to differentiate definitively between genetic
inheritance and imprinting, analysis of DNA methylation in
primary tissues from a family is necessary. Analysis of a family
allows for the determination of a SNP’s parental origin along with
inheritance patterns of DNA methylation levels and therefore
permits the direct examination of genetic and epigenetic
mechanisms of differential methylation. By analyzing DNA
methylation in a family, the impact of alleles verses the impact
of a chromosome’s parental origin on the inheritance of
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methylation can be clearly resolved. Surveying DNA methylation
in multiple related and unrelated individuals also enables
quantitative estimation of the effect of genotypic variation on
DNA methylation levels.
Examination of DNA methylation patterns in twins has
indicated that related individuals exhibit more similar DNA
methylation than unrelated individuals, implying that genetics
plays a role in establishing DNA methylation patterns. Baranzini
et al. [16] observed a striking similarity in DNA methylation
patterns between monozygotic twins that was not seen between
unrelated individuals. In addition, Kaminsky et al. [17] found that
monozygotic twins share similar DNA methylation patterns
compared to dizygotic twins; however, they suggest that this
similarity may be due to epigenetic events in the zygote as opposed
to genetic relatedness. Considering the promise of DNA
methylation as a disease biomarker [18], it is important to
determine the influence that genome sequence has on this
epigenetic mark.
To determine the genetic contribution to DNA methylation, we
quantified DNA methylation in non-immortalized peripheral
blood leukocytes from a three-generation family. We used reduced
representation bisulfite sequencing (RRBS) [19] to achieve single
molecule resolution of DNA methylation for a large number of
CpG dinucleotides distributed throughout the human genome. We
were able to find SNPs by sequencing and directly observing DNA
methylation on the same homologous chromosome. Our results
show that differential methylation of homologous chromosomes is
prevalent, transmitted through families in a genotype-dependent
manner, and linked with allele-specific gene expression.
Results
Allele-specific DNA methylation discovery by RRBS is
reproducible
To discover differential methylation on homologous chromo-
somes, we used reduced representation bisulfite sequencing (RRBS)
[19], which can be used to measure the DNA methylation state in a
subset of the genome in many samples. Because RRBS uses bisulfite
treatment, it detects both 5-methylcytosine and 5-hydroxymethyl-
cytosine [20]. Thus, the allelic differences identified by the method
can be differences in 5-methylcytosine or 5-hydroxymethylcytosine.
However, alleles that differ in the ratio between levels of 5-
methylcytosine and 5-hydroxymethylcytosine are not detectable.
We refer to the combination of these marks as DNA methylation.
We used the Illumina Genome Analyzer IIx (GAIIx) to sequence
36 base pair ends of bisulfite-treated MspI digestion fragments
ranging in length from 40 to 120 bp. For each sample, we assayed
approximately 1 million CpG dinucleotides with at least 10
sequencing reads, and calculated the percent of reads that are
methylated at each CpG. This type of deep sequencing also identifies
DNA sequence variants in the fragments for which we are measuring
methylation (seeMaterials andMethods). Detecting these SNPs in the
bisulfite sequence reads allows direct determination of whether a
particular allele is found in ciswithmethylated or unmethylated CpGs
(Figure 1A). Bisulfite treatment obscures C to T SNPs in forward
strand reads and G to A SNPs in reverse strand reads, because a C to
Tmismatch in forward strand reads could represent an unmethylated
cytosine and cannot be unambiguously called a SNP. We do not
analyze possible C to T SNPs in our sequence reads because they
cannot be identified. These SNPs account for approximately 30% of
human SNPs; thus, most SNPs remain observable.
We first measured DNA methylation on different alleles in the
human embryonic stem cell line H1 [21]. The majority of alleles
show no cis association with DNA methylation. At a 5% false
discovery rate (FDR), 5.4% (1,340 of 24,979) of autosomal
heterozygous SNPs are associated with allele-specific methylation
(ASM). In total, 1,340 SNPs are associated with ASM at 1,574
CpGs. Because a SNP can be linked to multiple CpGs and
multiple SNPs can be linked to the same CpG, we were able to
identify 1,937 ASM events in this cell line (all ASM data can be
found in Dataset S1; Table S1 provides a summary of ASM events
in each sample, including the number of heterozygous SNPs
called). Of the 1,937 ASM events, 573 (29.6%) involve a SNP that
mutates a CpG. These cases represent a trivial mechanism for
generating ASM because there is no longer a CpG to methylate
when the CpG-disrupting allele is present; however, they are
functional variants in that they result in a change in the
methylation status of a locus.
The average difference in percent methylation between alleles is
59.8% for ASM events that do not involve CpG disrupting SNPs
(Figure 1B). Less than 8% of ASM events exhibit greater than a
95% difference in percent methylation, which suggests that most
changes in genotype induce more subtle changes in the frequency
of DNA methylation than complete reversal of CpG methylation.
These quantitative differences in percent methylation between
alleles are highly reproducible. In two separate growths of the H1
cell line, the correlation of the difference in percent methylation
between the reference and variant allele for all ASM events in both
replicates is 0.98 (Figure 1C). These results show that measure-
ments of the quantitative differences in percent methylation
associated with SNPs are highly reproducible.
ASM associates with X chromosome inactivation
One of the two X chromosomes in women are randomly
silenced in each cell during development, and DNA methylation at
many sites has been shown to exist specifically on alleles from the
inactive X [10]. To assess our ability to observe inactivation of the
X chromosome and thus validate the ASM approach taken here,
we analyzed ASM in four clonal cell lines derived from single cells
of the EBV-transformed lymphoblastoid line GM12878. Gene
expression patterns indicate that two of these cell lines silence the
paternal X chromosome, while the other two cell lines silence the
maternal X chromosome (Table S2; K.S.K. and H.F.W.,
manuscript in preparation). We observed reproducible patterns
Author Summary
DNA methylation is a dynamic epigenetic mark that is
essential for mammalian organismal development. DNA
methylation levels can be influenced by environment, a
chromosome’s parental origin, and genome sequence. In
this study, we evaluated the impact that DNA sequence
has on DNA methylation by analyzing methylation levels in
a three-generation family as well as unrelated individuals.
By following DNA methylation patterns through the family
along with nearby SNPs, we found that allelic differences
between chromosomes play a much larger role in
determining DNA methylation than the parental origin of
the chromosome, indicating that DNA sequence has a
larger impact on DNA methylation than gametic imprint-
ing. We also found that allelic differences in DNA
methylation found in the family can also be observed in
unrelated individuals. In fact, the majority of variation in
DNA methylation can be explained by genotype. Our
results emphasize the importance of genome sequence in
setting patterns of DNA methylation and indicate that
genotype will need to be taken into account when
assessing DNA methylation in the context of disease.
Genetic Influence on DNA Methylation
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of ASM on the X chromosome (Figure S1). Clones with an
inactivate X chromosome from the same parental lineage
exhibited the same allelic bias for every ASM event on the X
chromosome (e.g., either the variant allele was more methylated in
each clonal line or the reference allele was more methylated in
each clonal line). When comparing any maternal X-inactive clone
with any paternal X-inactive clone, an average of 59.7% of ASM
events on the X chromosome switch the allele that is most often
methylated, which is consistent with the pattern of inactivation. Of
the genes nearby the ASM events that are consistent with
inactivation, six were previously assayed for allelic expression [22]
and all six were identified as being inactivated. Because
inactivation is not complete across the chromosome, we do not
expect all ASM to switch the most often methylated allele when
the inactive X chromosome is switched. These results demonstrate
that our method is sensitive to X inactivation in single cell clones;
however, many ASM events on the X chromosome are driven by
allele status rather than by parental origin.
ASM is prevalent in a three-generation family
To determine the prevalence of ASM throughout the human
genome and to deconvolute whether it is dependent on DNA
sequence variants or parental origin imprinting, we applied RRBS
to DNA extracted from leukocytes in fresh blood from six
members of a three-generation family as well as two unrelated
individuals (Figure 2A). We collected data for more than 950,000
CpGs that had at least ten sequencing reads in each family
member. Overall, 859,531 CpGs had at least 10 sequencing reads
in all samples and 668,545 had at least 20 sequencing reads in all
samples. Leukocytes from fresh blood are comprised of a
heterogeneous population of cells, consisting primarily of neutro-
phils, lymphocytes and monocytes. It has been shown that the
relative proportion of each cell type does not considerably affect
DNA methylation levels [23]. Consistent with this observation, we
found that the patterns of DNA methylation are strikingly similar
between the family members. The average correlation in percent
methylation of all autosomal CpGs assayed between any two
family members is 0.985. All of the samples assayed were highly
similar, indicating that there were no systematic biases in DNA
isolation, library preparation or DNA sequencing.
Analysis of the CpGs that vary within the eight individuals
reveals that DNA methylation patterns recapitulate relatedness.
We clustered individuals based on the methylation status of the top
237 most varying autosomal CpGs across all samples. The
Figure 1. Discovery of ASM by reduced representation bisulfite sequencing. (A) Example of bisulfite sequencing reads from a region with a
SNP (T/G; yellow) that is associated with methylation levels. Methylated cytosines, which appear as C’s in the bisulfite reads, are shown in red. (B)
Distribution of the difference in percent methylation of the reference allele and the variant allele is shown for all CpGs that are nearby a SNP (blue)
and ASM CpGs that do not involve CpG-disrupting SNPs (red). (C) The difference in percent methylation of the reference allele and the variant allele
for ASM events not involving a CpG-disrupting SNP from two biological replicates of the hESC H1 line.
doi:10.1371/journal.pgen.1002228.g001
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resulting tree, based on hierarchical clustering, is shown in
Figure 2B. The two unrelated individuals are separated from the
family members and serve as an out-group. Genetically unrelated
pairs of family members (e.g., maternal grandmother and father,
and father and mother in the middle generation) are also separated
in the tree. The closest relationships in DNA methylation patterns
exist between the grandmothers and their children and the
methylation patterns in the grandchildren are mixtures of their
parents’ methylation patterns. These results indicate that DNA
methylation levels can capture the relatedness of individuals,
suggesting that there is a strong genetic component to DNA
methylation levels.
We identified an average of 1,702 ASM events for each member
of the family. When individuals are clustered on CpGs that exhibit
ASM in at least one individual (Figure 2C), the same relationships
are observed as those shown in Figure 2B. To look at features of
CpGs exhibiting ASM, we focused on 2,391 autosomal ASM
events that we identified in at least two of the six family members.
42.6% (1,018) of these ASM events are SNPs that mutate a CpG.
The high prevalence of CpG-disrupting SNPs is not due to higher
sequence coverage (Table S3). Our analysis showed that SNPs that
disrupt CpGs tend to lie in intergenic regions that are not CpG
islands. Only 21.9% of CpGs that are disrupted by SNPs are
found in CpG islands, while 65% of all CpGs queried by RRBS
reside in CpG islands (P,2.2610216; Fisher’s exact test). CpGs
that are disrupted by SNPs are over-represented in intergenic
regions, as 44.1% are at least 2 kilobase pairs (kb) away from the
nearest gene, compared to 22% of all CpGs assayed by RRBS that
are at least 2 kb away from the nearest gene (P,2.2610216;
Fisher’s exact test). SNPs that mutate a CpG are often linked to the
methylation status of other CpGs in the immediate vicinity. More
than 45% of CpG-mutating ASM SNPs exhibit ASM associated
with at least one other CpG within 36 base pairs, which represents
a 5.5-fold increase in the chance that a CpG with a CpG-
disrupting SNP in the same read shows allele specificity
(P,2.2610–16; Fisher’s exact test). These data demonstrate that,
while CpG-disrupting SNPs alter DNA methylation at their
particular position due to a DNA sequence difference, they also
influence the methylation of nearby CpGs. This is further evidence
that there is a strong genetic effect on the regulation of DNA
methylation.
ASM events that do not involve a mutated CpG are under-
represented in CpG islands and are most often located in
intergenic regions, as were CpGs disrupted by SNPs. Only
49.4% of CpGs that exhibit ASM are present in CpG islands, even
though 65% of CpGs with nearby SNPs assayed by RRBS are in
islands (Figure 3A; P,2.2610216: Fisher’s exact test). Figure 3B
shows the distribution of gene features for CpGs that exhibit ASM.
The majority of ASM CpGs are present in intergenic regions, even
though most CpGs with nearby SNPs assayed by RRBS are
present in promoters, first introns or first exons. There is a 3.5-fold
increase in the fraction of CpGs that reside in intergenic regions
(P,2.2610216; Fisher’s exact test). The overall trends of where
ASM events are located in the genome are not the result of
differences in coverage between these categories of SNPs (Table
S3). The tendency for ASM CpGs to be located outside of CpG
islands and further away from genes may indicate that ASM events
occur in regions under less selective pressure.
Because ASM tends to occur in regions without clear regulatory
function, we looked at evolutionary constraint at these sites by
analyzing mammalian alignments. ASM events involving SNPs
that disrupt CpGs and SNPs that do not disrupt CpGs were found
more often outside of CpG islands and in intergenic regions. We
therefore assayed both sets and determined the level of
evolutionary conservation in each group. We found significantly
less conservation in CpG-disrupting ASM events (P=0.008;
Wilcoxon test) and non-CpG-disrupting ASM events (P=0.002;
Wilcoxon test) compared to all assayed regions that contained
SNPs. To determine if this reduction in conservation could be
explained by the overabundance of ASM events in intergenic
regions, we repeated the conservation analysis using only SNPs in
intergenic regions. We found that even within intergenic regions,
Figure 2. Methylation patterns recapitulate family relationships. (A) Pedigree is shown for family members analyzed (A–F) as well as
unrelated individuals G and H. (B) Hierarchical clustering of the most variable CpGs across all of the individuals. (C) Hierarchical clustering of CpGs that
exhibit ASM in at least one individual. Letters at the top of each cluster refer to letters in the pedigree.
doi:10.1371/journal.pgen.1002228.g002
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SNPs associated with ASM were significantly less conserved than
all intergenic SNPs assayed (Figure 3C). This was true for both
CpG-disrupting ASM events (P=0.009; Wilcoxon test) and non-
CpG-disrupting ASM events (P=0.007; Wilcoxon test). These
data are consistent with the hypothesis that there is evolutionary
constraint on DNA methylation levels, as genetic variants that
affect DNA methylation tend to lie in regions under less selective
pressure.
Genotype influences allelic methylation more often than
parental origin
By carrying out RRBS in a family, we were able to follow SNPs
through each generation and determine whether ASM is
associated with the identity of the SNP or with parental origin.
To distinguish these modes of transmission, we first had to identify
SNPs with unambiguous inheritance in the pedigree that switched
parental origin (e.g., those SNPs that have a maternal origin in one
generation and a paternal origin in the next). We then identified
those SNPs that were associated with ASM in both parent and
child. We identified 432 autosomal ASM events in which the
variant allele switched parental origin in the family. We then
eliminated the 341 of these ASM events that were due to SNPs
that mutated a CpG, as these are necessarily associated with the
identity of the SNP. Only 7 (7.7%) of the remaining 91 ASM
events displayed a methylation pattern that followed parental
origin. The methylation patterns of the other 84 ASM events
depended on the DNA sequence and an example is shown in
Figure 4A. These results indicate that, in most cases, an allele’s
sequence plays a larger role in determining DNA methylation than
an allele’s parental origin.
While the majority of ASM events depend on the underlying
allelic sequence, we found seven autosomal ASM events that are
consistent with a genetic imprinting mode of transmission. These
events occur in five distinct loci, most of which are intergenic. The
introns of OVOS1 and TRAPPC9 both contain parent-of-origin
ASM events, while the other three loci are at least 20 kb from the
nearest gene. Figure 4B shows ASM of TRAPPC9 (also know as
NIBP), which is involved in neuronal NF-kB signaling [24] and is
thought to have a maternal effect on height [25]. The TRAPPC9
SNP mutates a CpG, which exhibits ASM that follows the
sequence of the allele as expected. However, the CpG located
32 bp away is unmethylated on the variant allele in the mother
(which came from her father) and is methylated on the variant
allele in both sons. The RRBS data suggests that parent-of-origin
ASM may extend further in this region, as CpGs extending 65 bp
upstream and 125 bp downstream of the SNP are all close to 50%
methylated in every member of the family. The transcription start
site of KCNK9, a known maternally imprinted gene [26], resides
downstream of TRAPPC9 more than 350 kb away from the SNP.
It is possible that methylation of a TRAPPC9 intron is involved in
silencing KCNK9. The TRAPPC9 region represents a candidate
for maternal imprinting, which provides supporting evidence for
the locus’ role in maternal effect on height.
Because genotype-dependent differences in DNA methylation
were far more prevalent than parental origin-dependent differ-
Figure 3. ASM is often found in regions that are outside of CpG
islands, away from genes, and that exhibit low evolutionary
conservation. (A) The percentage of CpGs found in CpG islands is
shown for all CpGs and ASM CpGs. (B) The distribution of genomic
locations with respect to genes is shown for all CpGs (blue) and ASM
CpGs (red). (C) The distribution of evolutionary conservation scores
(phyloP) for intergenic SNPs is shown as a boxplot for all SNPs near
CpGs, ASM SNPs in which a SNP mutates a CpG, and ASM SNPs in which
a SNP does not mutate a CpG. The midline represents the median
conservation score and the box represents the 25% and 75% quantiles.
doi:10.1371/journal.pgen.1002228.g003
Genetic Influence on DNA Methylation
PLoS Genetics | www.plosgenetics.org 5 August 2011 | Volume 7 | Issue 8 | e1002228
ences, we built a general model of DNA methylation and genotype
that was able to incorporate information from homozygous
individuals. We built a linear model of the relationship between
DNA methylation and genotype that assumes that a CpG’s
methylation level in a heterozygous individual is halfway between
the level of methylation in an individual homozygous for one allele
and an individual homozygous for the other allele. When the
model is constructed for the top 2,900 most variable CpGs in the
family that have detectable SNPs nearby, 602 (20.8%) showed
significant genotype contributions and 370 (12.8%) were still
significant after multiple hypothesis correction. Even with a small
sample size of six, genetic association with DNA methylation is
detectable for a large number of loci. These results, together with
ASM data, suggest that DNA sequence plays a major role in
determining inter-individual differences in DNA methylation
levels.
ASM is also observed in unrelated individuals
Some of the genetically linked ASM events found in the family
may be dependent on genetic background and specific to the
particular family studied, while other ASM events may be
common to many individuals. To determine the persistence of
ASM in different genetic backgrounds, we analyzed two unrelated
individuals as well as the lymphoblastoid cell line GM12878. We
could test 40 of the 84 sequence-dependent autosomal regions that
we observed in the family because at least one unrelated individual
was heterozygous at the same SNP as that observed in the family.
30 of those 40 regions (75%) were found to be allele-specific in the
unrelated individuals as well. In every case, the more often
methylated allele in the family was also more often methylated in
the unrelated individuals. We also found that the CpGs in the
TRAPPC9 locus discussed above were also methylated between
39% and 57% in the unrelated individuals, which is consistent
with parental origin imprinting at this locus. These results indicate
that many ASM events that we observed in the family are present
in other genetic backgrounds.
For a broader view of the influence of genotype on DNA
methylation, we used the linear model of DNA methylation and
genotype discussed above to predicted DNA methylation levels in
the two unrelated individuals. In both individuals, the model was
able to predict methylation levels with high accuracy based on
each individual’s genotype (R2=0.82 and 0.83). The ability of the
linear model, which was trained on the family, to predict DNA
methylation in unrelated individuals accurately shows that the
relationship between DNA sequence and methylation levels is
consistent among individuals.
While the influence of genotype could be observed across
individuals in the same tissue, we sought to determine whether the
impact of DNA sequence on DNA methylation could be observed
in different tissues from the same individual. We analyzed DNA
extracted from kidney and skeletal muscle of a third unrelated
individual. There were 1,521 ASM events in the kidney sample
and 1,332 ASM events observed in the skeletal muscle sample. Of
the 984 ASM events observed in the kidney with sufficient
coverage in both samples, 834 (84.8%) were also allele-specific in
skeletal muscle. For all 834 overlapping ASM events, the more
often methylated allele was identical in the kidney and skeletal
muscle samples. If CpG disrupting SNPs are removed from the
analysis, there were 931 ASM events in the kidney sample and 790
events observed in the skeletal muscle sample. Of the 614 ASM
events observed in the kidney with sufficient coverage in both
samples, 445 (72.5%) were also allele-specific in skeletal muscle.
These results indicate that allelic differences in DNA methylation
can be observed across different tissues in the same individual at a
high frequency.
ASM associates with gene expression differences
To determine whether ASM events are indicative of functional
gene regulatory differences, we compared ASM with allele-specific
gene expression (ASE; T.E.R. et al., manuscript in preparation) in
the original lymphoblastoid line GM12878. Of the autosomal
genes that have an ASM event within 5 kb of the transcription
start site, we found that 21.7% (18 out of 83) of the autosomal
genes with sufficient RNA-seq read depth (greater than 25 reads
that cover SNPs) show ASE (Table S4). This represents more than
a two-fold enrichment (P=4.261024; hypergeometric test) over
an overall rate of 9.2% (594 out of 6464) of ASE for all autosomal
genes with sufficient read depth. Data for the gene encoding acid
alpha-glucosidase (GAA) are summarized in Figure 5. GAA, which
is involved in the degradation of glycogen to glucose and is
Figure 4. Inheritance of ASM in the family. The pedigree of the family is shown with their allele status at (A) chromosome 21 position
45,989,210, which is in an intron of c21orf29, and (B) chromosome 8 position 141,109,575, which is in an intron of TRAPPC9. Next to the assayed
individuals, each line with two dots on the ends represents 5 sequence reads. The dot on the left side of each line represents the methylation status
of the nearby CpG (black: methylated; white: unmethylated). The dot on the right side of the each line represents the allele status of the SNP (blue:
reference allele and red: variant allele).
doi:10.1371/journal.pgen.1002228.g004
Genetic Influence on DNA Methylation
PLoS Genetics | www.plosgenetics.org 6 August 2011 | Volume 7 | Issue 8 | e1002228
associated with Pompe’s disease [27], showed 3% methylation on
the maternally inherited copy of chromosome 17 and 89%
methylation on the paternally inherited copy; RNA-seq showed
that 76.7% of the transcripts came from the maternal copy of
chromosome 17. TRAPPC9 and OVOS1 did not harbor SNPs
with sufficient read depth in the RNA-seq data to determine allele-
specificity. These results indicate that genes exhibiting ASM are
enriched for gene expression differences between alleles.
Independent validation of ASM and ASE
We sought to validate the next generation sequencing results by
performing Sanger sequencing on a small number of loci. To
investigate ASM, we performed bisulfite PCR, cloning and Sanger
sequencing of four loci from family member C (Figure 6). All four
loci exhibited ASM in the Sanger sequencing data. We also
observed that the allele-specificity of DNA methylation extended
beyond the region assayed by RRBS. In two cases, (chr21:4415835
and chr8:141109575) allele-specificity was found across the entire
region. In the other two examples, half of the assayed region
exhibited allele-specificity, while the other half of the region was
similar between the two alleles. These results indicate that ASM
identified in the RRBS data is also observed with Sanger
sequencing and that patterns of ASM are complex.
To look further at extended ASM, we analyzed SNPs within
200 bp of each other and found that adjacent SNPs were often
concurrently associated with ASM. For example, in family
member A 655 ASM SNPs have another SNP detected within
200 bp and 455 (71.4%) of these SNPs also exhibit ASM. On
average across the family members, 76.3% of SNPs adjacent to
ASM SNPs were also associated with ASM themselves. These
results show that ASM can be seen across extended regions.
To validate the next generation ASE findings, we cloned and
Sanger sequenced genomic DNA and cDNA from GM12878 for
six loci. Using the ratio of alleles observed in the genomic DNA as
a background, we found that five (GAA, KCNQ10T1, HLA-
DPB2, LOC654433 and LOC253039) loci exhibited significant
allele biased expression with the bias coming from the expected
parental chromosome. ZNF132 showed a bias in the expected
direction (69% from the allele predicted to be higher expressed);
however, the number of reads (16), was too low to call the bias
significant. Both ASE and ASM validation results show that the
allele-specificity observed with our next generation sequencing
approaches are replicated with an independent technique.
Discussion
Using short-read, ultra high-throughput DNA sequencing, we
identified reproducible quantitative differences in DNA methyla-
tion between alleles. When we observe allele-specific DNA
methylation, the differences in methylation levels between
Figure 5. Allele-specific gene expression overlaps with ASM. Methylation of upstream CpG on each allele is shown in a pie chart with dark
gray representing the fraction of CpG sites that is methylated and light gray representing the fraction unmethylated (left side). The fraction of mRNA
that comes from each allele is shown for GAA (right side).
doi:10.1371/journal.pgen.1002228.g005
Figure 6. ASM extends past regions assayed by RRBS. Results from Sanger sequencing of bisulfite PCR clones are shown for four loci where
the chromosomal location indicates the position of the SNP. Each line represents one read where black circles represent methylated CpGs, white
circles represent unmethylated CpGs, blue circles represent the reference allele and red circles represent the variant allele. Green lines demarcate the
region assayed by RRBS. The distance from the SNP to the boundaries of the region is shown below each loci.
doi:10.1371/journal.pgen.1002228.g006
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homologous chromosomes are rarely completely reversed. The
abundance of subtle differences indicates that some alleles
influence the propensity of DNA methylation within a cell
population, but do not completely exclude or cause methylation.
ASM events were found outside of CpG islands and were highly
enriched in intergenic regions. Because ASM tends to occur in
regions without clear regulatory function, we looked at evolution-
ary constraint at these sites. ASM tends to be found in genomic
locations with significantly low levels of evolutionary conservation.
This result is consistent with the hypothesis that there is selective
pressure to maintain DNA methylation, as we found that most
alleles that affect DNA methylation exhibit less evolutionary
constraint. Selection may be acting on the underlying events that
lead to DNA methylation or directly on the ability to methylate a
particular sequence, as is the case with SNPs that mutate CpGs.
We found that DNA methylation levels could distinguish family
members from unrelated individuals and capture family relation-
ships. By analyzing six members of a three-generation family, we
were able to follow the patterns of inheritance of both DNA
methylation and the SNPs associated with methylation levels
directly. When the parental origin of a SNP switched between
generations, the vast majority of ASM events were genotype-
dependent and followed a particular sequence variant rather than
parental origin. These results show that DNA sequence plays a
larger role in establishing DNA methylation patterns than do
parental origins. We found that the majority of the ASM events
seen in the family could also be observed in other individuals,
indicating that the ASM events observed are not specific to the
family described here and that the alleles have the same influence
on DNA methylation in different genetic backgrounds.
The strong association between genotype and DNA methylation
indicates that genetics plays a prominent role in the establishment
of DNA methylation patterns. Our data supports a non-
Lamarckian model of evolution, where genetic variants, as
opposed to environment, shape epigenetics [28]. These genetic
variants may not lead directly to phenotypic differences, but may
cause phenotypic variability through changes in epigenetic states.
While ASM events could be observed across individuals in the
same cell type, we also observed a concordance of ASM between
tissue types. The fact that we see a strong overlap between ASM in
different tissues indicates that these allelic differences are most
likely due either to shared gene regulatory events that occur early
in development or an inherent property of DNA sequence that
directly affects the propensity of DNA methylation. The
prevalence of ASM in different tissues brings up the possibility
that methylation at these loci are directly inherited with the
haplotype through the germline. While the prevailing model of
DNA methylation would suggest that methylation patterns are
erased during gamete formation and just after fertilization [29],
the possibility exists that DNA methylation is being constantly
maintained for these loci in an allele-specific manner. Our data are
consistent with both the re-establishment of allelic methylation
during development and the direct transmission of DNA
methylation in the germline, and cannot distinguish between
these modes of transmission.
There may be alleles that influence the conversion of 5-
methylcytosine to 5-hydroxymethylcytosine by the TET family of
enzymes. Because the use of bisulfite sequencing does not
distinguish between modifications, these alleles would not be
detectable in our data. It will be interesting to determine if newly
described genome scale methods [30–32] will be able to identify




We extracted high molecular weight genomic DNA from 8 ml
of blood from each individual. The buffy coats from each sample
were isolated by centrifugation. Buffy coat was gently mixed and
incubated for 30 minutes with lysis buffer at room temperature
(0.32 M Sucrose, 10 mM Tris-HCl pH 7.5, 5 mMMgCl2 and 1%
Triton X-100), then centrifuged at 4uC at 2500 rpm for
20 minutes. The supernatant was discarded, and the pellet was
vortexed with 20 ml lysis buffer, then centrifuged at 4uC at
2,500 rpm for 20 minutes. The supernatant was discarded and the
pellet was incubated in 5 ml guanidine isothiocyanate buffer on a
shaker for 25 minutes (5 M Guanidine thiocyanate, 25 mM
sodium acetate, 0.84% beta-mercaptoethanol). 5 ml 4uC isopro-
panol was added and the sample was inverted gently until
precipitate appeared. Samples were then incubated at 220uC for
at least one hour, and centrifuged at 4uC at 2,500 rpm for
20 minutes. The supernatant was then discarded and 500 ml
T10E.2 (10 mM Tris-HCl pH 7.4, 2 mM EDTA pH 8.0), 50 ml
3 M sodium acetate pH 5.2, and 1 ml 100% ethanol were added
and mixed and the DNA was precipitated by centrifuging at
12,000 rpm for 30 seconds. The supernatant was discarded and
the pellet was washed with 500 ml 70% ethanol and centrifuged at
12,000 rpm for 30 seconds. The supernatant was discarded and
the DNA was allowed to air-dry for 10 minutes. The genomic
DNA pellet was resuspended in 1 ml T10E.2 buffer by gentle
vortexing.
For GM12878 and H1 hESC, cells were grown according to
ENCODE standards [33]. To generate the clonal cell lines,
GM12878 was cultured according to the ENCODE protocol. At
the time of culturing, the original GM12878 cell line was heavily
skewed (92%) towards the paternally inherited inactive X
chromosome [34]. To obtain pure populations of cells with an
inactivated maternal X chromosome (Ximat) or an inactivated
paternal X chromosome (Xipat), single cell clones of GM12878
were obtained by serial dilution. Each selected clone was tested for
complete nonrandom inactivation by a PCR-based SNaPshot
expression assay [22] using heterozygous SNPs in monoallelically
expressed X-linked genes (Table S2; K.S.K. and H.F.W.,
manuscript in preparation). Four clones (two with Ximat and two
with Xipat) were chosen for further study. For all cell lines, DNA
was extracted from cell pellets using a DNeasy kit (Qiagen)
according to the manufacturer’s instructions. Kidney and skeletal
muscle genomic DNA from the same donor was purchased from
BioChain (Hayward, CA). Genomic DNA was quantified using
fluorescent DNA binding dye and a fluorometer (Invitrogen
Quant-iT dsDNA High Sensitivity Kit and Qubit Fluorometer).
Reduced representation bisulfite sequencing
Reduced representation bisulfite sequencing (RRBS) was
performed as described [35]. Briefly, 1 mg genomic DNA was
digested with the methylation insensitive restriction enzyme MspI
(NEB). Ends of each restriction fragment were filled in and a 39
adenosine was added with Klenow Fragment (39R59 exo-minus;
NEB). Methylated paired-end Illumina adapters were ligated to
the ends of the DNA fragments using T4 DNA Ligase (NEB).
Fragments between 105 bp and 185 bp were purified by agarose
gel extraction. The purified fragments were treated with sodium
bisulfite and then amplified by PCR with long-range PCR
conditions and Platinum Taq Polymerase (Invitrogen). The final
PCR products were sequenced on Illumina GAIIx machines. All
of the sequence data that is presented is of high quality with
average quality scores of more than 25 for each cycle. Sequence
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data for the cell lines as well as the kidney and skeletal muscle
tissue as available through the UCSC genome browser’s [33]
ENCODE DNA methylation track: HAIB Methyl RRBS.
Sequence data for the primary blood leukocytes can be found
under Gene Expression Omnibus (GEO) submission GSE30253.
Computational discovery of ASM
All analysis was performed using the February 2009 (GRCh37/
hg19) build of the human genome. To determine instances of
ASM, we first converted all cytosines in sequence reads to
thymidines. We did the same to the reference genome sequence
and then aligned the converted sequence reads to the converted
reference sequence using Bowtie [36] to look for unique
alignments. We required the read be uniquely aligned to only
the best position in the converted reference, and that the reference
position be the best and unique alignment to itself across the
reference genome. We then identified the CpG positions in the
unconverted reference sequence, and calculated the fraction of
original sequence reads that have a C in that position. We
performed further analysis only on CpGs with at least 146 read
depth coverage. Bowtie also identifies mismatches between the
reads and the reference, so we used it to look for common
mismatches in the alignments to identify SNPs. We required at
least 7 instances of the same mismatch and also required that the
mismatch be found in at least 10% of the total reads that cover
that position. We did not use an existing software tool to identify
SNPs because the bisulfite reads do not align to a standard genome
and all of the reads that cover a potential SNP start at one
particular position due to the restriction digest. When analyzing
the distribution of SNPs, we found that ASM SNPs that involve a
reference G are the most prevalent, which is due to CpG-
disrupting SNPs (Table S5). The next most prevalent SNPs involve
a reference T, which is most likely due to extra Ts in the reference
genome, since both Cs and Ts are represented as Ts in our
bisulfite reference genome.
For each called SNP, we determined whether the SNP was
heterozygous by requiring that at least 7 sequence reads contain
the reference allele. Then for each SNP-CpG pair that is present
in the same 36 bp read, we calculated the amount of methylation
on the variant allele and the reference allele. To test association of
the SNP and the methylation status of the CpG, we performed a
Fisher’s Exact Test and calculated q-values [37] to assess false
discovery rates for each SNP-CpG pair. To look at whether ASM
SNPs were from dubious SNPs at the lower quality ends of
sequence reads we determined the median distance between SNPs
and CpGs for SNP-CpG pairs that exhibit ASM and those that do
not. We found that the median distance was 8 bp in each class.
ASE and ASM validation
For Sanger sequencing validation, bisulfite PCR, cloning and
Sanger sequencing was performed as previously described [38].
For allele-specific methylation validation a Fisher’s exact test was
used to determine significance with a p-value cutoff of 0.05. For
allele-specific expression we compared the proportion of reads
coming from each allele in the genomic DNA clones to the
proportion of reads coming from each allele in the cDNA clones.
A binomial test was used to determine significant allele-specific
expression with a p-value cutoff of 0.05.
CpG island, conservation, and gene feature discovery
CpG island locations [39], phyloP [40] scores (Mammalian
Cons – phyloP46wayPlacental) and RefSeq [41] exon locations
were downloaded from the UCSC genome browser [42].
Clustering and linear model of DNA methylation and
genotype
Average linkage hierarchical clustering based on Euclidean
distances was performed on the top 237 most varying CpGs as well
as all CpGs that exhibited ASM across the 8 buffy coat samples
using the software package Cluster 3.0 [43]. TreeView [44] was
used to visualize the data.
A linear model relating genotype and methylation levels was
constructed in R. A CpG-SNP pair was analyzed only if the CpG
had a standard deviation in percent methylation of at least 25
across family members and the SNP exhibited at least two
different genotypes. Genotype values were assigned as follows:
0 = homozygous reference allele, 0.5 = heterozygous, and 1= ho-
mozygous variant allele. We required at least 25 reads covering
each SNP to assure that there were no errors in genotype calls. For
each CpG-SNP pair, the percent methylation was regressed on the
genotype value. ANOVA was then performed to calculate a p-
value for each model. We then calculated q-values to assess false
discovery rates and considered any model with a false discovery
rate less than 5% to be significant.
Discovery of ASE
RNA-seq was performed as previously described [45] and the
analysis is discussed in greater detail elsewhere (T.E.R., et al.
manuscript in preparation). To discover ASE, we first created and
aligned RNA-seq reads to RefSeq transcripts assembled from a
modified genome sequence that contains both haplotypes of
GM12878. We obtained SNP and haplotype information from the
1000 Genomes Project [46]. After alignment, the number of reads
aligned to each copy of each transcript was calculated. Then a
binomial test was used to determine significance and false
discovery rates [47] were calculated in R. Transcripts with a false
discovery rate less than 5% were considered to harbor allele-
specific expression. We used a cutoff of 25 reads, so that at least an
80% bias towards one allele could be detected as significant.
Supporting Information
Dataset S1 ASM events in each sample.
(TXT)
Figure S1 Comparison of ASM in clonal cell lines derived from
the lymphoblastoid line GM12878 with different inactive X
chromosomes. Each plot shows the difference in percent
methylation of the reference allele and the variant allele for
ASM events from two clonal cell lines. Each black circle represents
an autosomal ASM event and each red circle represents an X
chromosome ASM event. When comparing a line with a paternal
inactive X chromosome (Xi-pat) vs. a line with maternal inactive
X chromosome (Xi-mat) an average of 59.7% of X chromosome
ASM events switch which allele is more often methylated. The
results are consistent with DNA methylation being associated with
X chromosome inactivation.
(PDF)
Table S1 Prevalence of ASM in each sample.
(XLS)
Table S2 Allele-specific expression of ATRX and TBL1X, genes
expressed from the active X chromosome, indicate that two clones
inactivate the maternally inherited X chromosome and two clones
inactivate the paternally inherited X chromosome.
(XLS)
Table S3 SNP coverage by category.
(XLS)
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Table S4 Overlap between ASM and ASE.
(XLS)
Table S5 Distribution of nucleotides in ASM SNPs.
(XLS)
Acknowledgments
The authors thank the donors who anonymously provided blood samples,
as well as Greg Barsh, Chris Gunter, Devin Absher, Shawn Levy, and the
members of the Myers lab for their contributions and helpful suggestions.
Author Contributions
Conceived and designed the experiments: JG KEV RMM. Performed the
experiments: KEV JG SLP KMB FP. Analyzed the data: JG KEV TER.
Contributed reagents/materials/analysis tools: KSK HFW. Wrote the
paper: JG.
References
1. Okano M, Bell DW, Haber DA, Li E (1999) DNA methyltransferases Dnmt3a
and Dnmt3b are essential for de novo methylation and mammalian
development. Cell 99: 247–257.
2. Feinberg AP, Tycko B (2004) The history of cancer epigenetics. Nat Rev Cancer
4: 143–153.
3. Jones PA (2002) DNA methylation and cancer. Oncogene 21: 5358–5360.
4. Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, et al. (2008)
Epigenomic profiling reveals DNA-methylation changes associated with major
psychosis. Am J Hum Genet 82: 696–711.
5. Richardson B (2003) DNA methylation and autoimmune disease. Clin Immunol
109: 72–79.
6. Ling C, Groop L (2009) Epigenetics: a molecular link between environmental
factors and type 2 diabetes. Diabetes 58: 2718–2725.
7. Reik W, Walter J (2001) Genomic imprinting: parental influence on the genome.
Nat Rev Genet 2: 21–32.
8. Wilkins JF (2005) Genomic imprinting and methylation: epigenetic canalization
and conflict. Trends Genet 21: 356–365.
9. Hashimshony T, Zhang J, Keshet I, Bustin M, Cedar H (2003) The role of DNA
methylation in setting up chromatin structure during development. Nat Genet
34: 187–192.
10. Norris DP, Brockdorff N, Rastan S (1991) Methylation status of CpG-rich
islands on active and inactive mouse X chromosomes. Mamm Genome 1:
78–83.
11. Chandler LA, Ghazi H, Jones PA, Boukamp P, Fusenig NE (1987) Allele-specific
methylation of the human c-Ha-ras-1 gene. Cell 50: 711–717.
12. Silva AJ, White R (1988) Inheritance of allelic blueprints for methylation
patterns. Cell 54: 145–152.
13. Kerkel K, Spadola A, Yuan E, Kosek J, Jiang L, et al. (2008) Genomic surveys
by methylation-sensitive SNP analysis identify sequence-dependent allele-specific
DNA methylation. Nat Genet 40: 904–908.
14. Shoemaker R, Deng J, Wang W, Zhang K (2010) Allele-specific methylation is
prevalent and is contributed by CpG-SNPs in the human genome. Genome Res.
15. Zhang Y, Rohde C, Reinhardt R, Voelcker-Rehage C, Jeltsch A (2009) Non-
imprinted allele-specific DNA methylation on human autosomes. Genome Biol
10: R138.
16. Baranzini SE, Mudge J, van Velkinburgh JC, Khankhanian P, Khrebtukova I,
et al. (2010) Genome, epigenome and RNA sequences of monozygotic twins
discordant for multiple sclerosis. Nature 464: 1351–1356.
17. Kaminsky ZA, Tang T, Wang SC, Ptak C, Oh GH, et al. (2009) DNA
methylation profiles in monozygotic and dizygotic twins. Nat Genet 41:
240–245.
18. Laird PW (2003) The power and the promise of DNA methylation markers. Nat
Rev Cancer 3: 253–266.
19. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, et al. (2008) Genome-
scale DNA methylation maps of pluripotent and differentiated cells. Nature 454:
766–770.
20. Huang Y, Pastor WA, Shen Y, Tahiliani M, Liu DR, et al. (2010) The behaviour
of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS ONE 5: e8888.
doi:10.1371/journal.pone.0008888.
21. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, et al.
(1998) Embryonic stem cell lines derived from human blastocysts. Science 282:
1145–1147.
22. Carrel L, Willard HF (2005) X-inactivation profile reveals extensive variability in
X-linked gene expression in females. Nature 434: 400–404.
23. Talens RP, Boomsma DI, Tobi EW, Kremer D, Jukema JW, et al. (2010)
Variation, patterns, and temporal stability of DNA methylation: considerations
for epigenetic epidemiology. FASEB J 24: 3135–3144.
24. Hu WH, Pendergast JS, Mo XM, Brambilla R, Bracchi-Ricard V, et al. (2005)
NIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B
activation. J Biol Chem 280: 29233–29241.
25. Kent JW, Jr., Peterson CP, Dyer TD, Almasy L, Blangero J (2009) Genome-
wide discovery of maternal effect variants. BMC Proc 3 Suppl 7: S19.
26. Luedi PP, Dietrich FS, Weidman JR, Bosko JM, Jirtle RL, et al. (2007)
Computational and experimental identification of novel human imprinted genes.
Genome Res 17: 1723–1730.
27. Raben N, Plotz P, Byrne BJ (2002) Acid alpha-glucosidase deficiency
(glycogenosis type II, Pompe disease). Curr Mol Med 2: 145–166.
28. Feinberg AP, Irizarry RA (2010) Evolution in health and medicine Sackler
colloquium: Stochastic epigenetic variation as a driving force of development,
evolutionary adaptation, and disease. Proc Natl Acad Sci U S A 107 Suppl 1:
1757–1764.
29. Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev
16: 6–21.
30. Ficz G, Branco MR, Seisenberger S, Santos F, Krueger F, et al. (2011) Dynamic
regulation of 5-hydroxymethylcytosine in mouse ES cells and during
differentiation. Nature 473: 398–402.
31. Pastor WA, Pape UJ, Huang Y, Henderson HR, Lister R, et al. (2011) Genome-
wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 473:
394–397.
32. Williams K, Christensen J, Pedersen MT, Johansen JV, Cloos PA, et al. (2011)
TET1 and hydroxymethylcytosine in transcription and DNA methylation
fidelity. Nature 473: 343–348.
33. Rosenbloom KR, Dreszer TR, Pheasant M, Barber GP, Meyer LR, et al. (2010)
ENCODE whole-genome data in the UCSC Genome Browser. Nucleic Acids
Res 38: D620–625.
34. McDaniell R, Lee BK, Song L, Liu Z, Boyle AP, et al. (2010) Heritable
individual-specific and allele-specific chromatin signatures in humans. Science
328: 235–239.
35. Myers Lab RRBS Protocol. Available: http://myers.hudsonalpha.org/docu-
ments/Myers%20Lab%20RRBS%20Protocol%2003-24-10.pdf. Accessed 2011
July 1.
36. Langmead B, Trapnell C, Pop M, Salzberg SL (2009) Ultrafast and memory-
efficient alignment of short DNA sequences to the human genome. Genome Biol
10: R25.
37. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies.
Proc Natl Acad Sci U S A 100: 9440–9445.
38. Varley KE, Mutch DG, Edmonston TB, Goodfellow PJ, Mitra RD (2009) Intra-
tumor heterogeneity of MLH1 promoter methylation revealed by deep single
molecule bisulfite sequencing. Nucleic Acids Res 37: 4603–4612.
39. Gardiner-Garden M, Frommer M (1987) CpG islands in vertebrate genomes.
J Mol Biol 196: 261–282.
40. Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A (2010) Detection of
nonneutral substitution rates on mammalian phylogenies. Genome Res 20:
110–121.
41. Pruitt KD, Tatusova T, Maglott DR (2007) NCBI reference sequences (RefSeq):
a curated non-redundant sequence database of genomes, transcripts and
proteins. Nucleic Acids Res 35: D61–65.
42. Rhead B, Karolchik D, Kuhn RM, Hinrichs AS, Zweig AS, et al. (2010) The
UCSC Genome Browser database: update 2010. Nucleic Acids Res 38:
D613–619.
43. de Hoon MJ, Imoto S, Nolan J, Miyano S (2004) Open source clustering
software. Bioinformatics 20: 1453–1454.
44. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and
display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95:
14863–14868.
45. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B (2008) Mapping and
quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621–628.
46. Durbin RM, Abecasis GR, Altshuler DL, Auton A, Brooks LD, et al. (2010) A
map of human genome variation from population-scale sequencing. Nature 467:
1061–1073.
47. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I (2001) Controlling the false
discovery rate in behavior genetics research. Behav Brain Res 125: 279–284.
Genetic Influence on DNA Methylation
PLoS Genetics | www.plosgenetics.org 10 August 2011 | Volume 7 | Issue 8 | e1002228
